Advisory Roles
Bring scientific depth, transformative advice and practical strategic judgement to the decisions shaping your organisation’s future.
For boards, founders and leadership teams working across genomics, biotechnology, AI and related markets, I connect technology, governance and commercial realities with your priorities: immediate progress and the ability to build for sustainable, highly scalable, flexible long-term development.
An informed perspective on your next decisions
- Challenge assumptions and assess opportunities using scientific evidence and a broad view of the sector.
- Connect governance, organisational capacity, commercial priorities and technological requirements.
- Support lean, Agile and effective decision-making, connecting step-wise change with defensible advantage and impactful, highly scalable long-term development.
Support can include board or scientific advisory input, strategic reviews, scenario planning and recommendations, with the role and scope agreed around your organisation’s needs.
Relevant strategic leadership experience
Advisory work is grounded in experience spanning governance, scientific infrastructure, organisational change and commercial development. I specialise in future-scenario planning, strategic advantage, defensible advantage and impact ventures, using lean and Agile principles and data-grounded strategy.
- Chaired the board of a green-energy company with more than 35 staff, supporting the CEO, assessing organisational capacity and strengthening governance.
- As a trustee, helped guide a strategic pivot that developed into the UK’s largest funder focused specifically on reducing carbon emissions.
- Wrote many successful grant applications in biodata, cancer, neglected tropical diseases and AI, focusing on cutting-edge technology transfer, disproportionate impact and scalability.
- Co-wrote Genomics England’s cancer strategy. Retained all of her commercial clients (leading pharma and biotech) during her tenure by resolving delivery issues, developing services and shaping new partnerships.
- Contributed to successful Athena SWAN equality initiatives at multiple scientific organisations, turning inclusion goals into action plans, targets and organisational practice.
- Go-to-market strategy and seed-funding materials for a successful extended seed-funding raise for a biotech company.
Did you know?
In 2018, the SEC alleged that Theranos misled investors about what its blood-testing technology could do. For boards and leadership teams, independent challenge needs to happen before an attractive claim becomes a strategy, partnership or financial commitment. Advisory input helps test the assumptions behind those decisions.
Suitable for
- Biotech and genomics startups
- AI-biology companies
- Health and precision medicine organisations
- Venture studios and investment firms
- Foundations and public-interest organisations
- Policy, ethics and education initiatives
- Food, biodiversity and sustainability ventures
What colleagues and collaborators say
Excerpts from LinkedIn recommendations.
“Magdalena exercised calm and thoughtful leadership, with every word offered adding value to a situation. She demonstrated excellent negotiation skills as options and scenarios were considered.”
“She also contributed to the development of EMBL's first EDI strategy.”
What perspective would strengthen your decisions?
Book a meeting to discuss your organisation, its priorities and the advisory support you need. We can explore the role, scope and next steps together.